We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

GSK, Zofran Users To Pick 16 Potential MDL Bellwether Cases

Law360, Boston (May 17, 2018, 3:33 PM EDT) -- GlaxoSmithKline and the families who claim its anti-nausea medication Zofran caused various birth defects will each select eight cases to probe and possibly bring to trial in the multidistrict litigation’s final discovery phase, a Massachusetts federal judge ruled Thursday.

U.S. District Judge F. Dennis Saylor IV said the time is nearing for GSK and the families to begin picking appropriate cases to bring to trial and selected a number closer to what the families had asked for when the two sides squabbled over the scope of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re: Zofran (Ondansetron)Products Liability Litigation


Case Number

1:15-md-02657

Court

Massachusetts

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

F. Dennis Saylor, IV

Date Filed

October 13, 2015

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.